Serum Levels of Interleukin 6, a Potent Myeloma Cell Growth Factor, as a Reflect of Disease Severity in Plasma Cell Dyscrasias.

Journal of Clinical Investigation - United States
doi 10.1172/jci114392
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Society for Clinical Investigation

Related search

Plasma Cell Dyscrasias: A Current Perspective

Acta Haematologica
MedicineHematology
1982English

Interleukin-6 Functions as an Intracellular Growth Factor in Hairy Cell Leukemia in Vitro.

Journal of Clinical Investigation
Medicine
1993English

Plasma Cell Satellitism in Plasma Cell Myeloma

Journal of Clinical Pathology
MedicineForensic MedicinePathology
2006English

The Non-Coding RNA Landscape of Plasma Cell Dyscrasias

Cancers
Cancer ResearchOncology
2020English

Serum Interleukin-6 (IL-6) Levels in Children With Kawasaki's Disease (KD)• 115

Pediatric Research
Child HealthPediatricsPerinatology
1998English

Identification of a T Cell-Derived B Cell Growth Factor Distinct From Interleukin 2

Journal of Experimental Medicine
MedicineAllergyImmunology
1982English

Toothache as the Initial Symptom of Plasma Cell Myeloma

European Journal of Dentistry
Dentistry
2018English

Prognostic Significance of Serum Hepatocyte Growth Factor in Clear Cell Renal Cell Carcinoma: Comparison With Serum Vascular Endothelial Growth Factor

Journal of Medical Investigation
BiochemistryMedicineGeneticsMolecular Biology
2008English

Interleukin-6: A Potent Biomarker of Mycobacterial Infection

SpringerPlus
Multidisciplinary
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy